News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
50,545 Results
Type
Article (4695)
Company Profile (4)
Press Release (45846)
Section
Business (13509)
Career Advice (228)
Deals (2191)
Drug Delivery (9)
Drug Development (4818)
Employer Resources (3)
FDA (794)
Job Trends (831)
News (22166)
Policy (2217)
Tag
Academia (314)
Accelerated approval (2)
Adcomms (3)
Allergies (3)
Alliances (4834)
ALS (18)
Alzheimer's disease (70)
Antibody-drug conjugate (ADC) (16)
Approvals (795)
Artificial intelligence (53)
Autoimmune disease (2)
Automation (4)
Bankruptcy (16)
Best Places to Work (581)
BIOSECURE Act (2)
Biosimilars (2)
Biotechnology (8)
Bladder cancer (1)
Breast cancer (13)
Cancer (158)
Cardiovascular disease (20)
Career advice (200)
Career pathing (3)
CAR-T (4)
Cell therapy (19)
Clinical research (3811)
Collaboration (120)
Compensation (20)
Complete response letters (2)
COVID-19 (200)
CRISPR (9)
C-suite (45)
Cystic fibrosis (4)
Data (326)
Depression (11)
Diabetes (24)
Diagnostics (365)
Digital health (3)
Diversity, equity & inclusion (2)
Drug discovery (38)
Drug pricing (9)
Drug shortages (3)
Duchenne muscular dystrophy (2)
Earnings (3481)
Editorial (4)
Employer resources (3)
Events (4989)
Executive appointments (50)
FDA (939)
Funding (90)
Gene editing (12)
Generative AI (6)
Gene therapy (29)
GLP-1 (74)
Government (327)
Grass and pollen (1)
Guidances (20)
Healthcare (740)
HIV (1)
Huntington's disease (5)
IgA nephropathy (3)
Immunology and inflammation (9)
Immuno-oncology (1)
Indications (7)
Infectious disease (212)
Inflammatory bowel disease (9)
Influenza (8)
Intellectual property (23)
Interviews (44)
IPO (659)
IRA (4)
Job creations (252)
Job search strategy (165)
JPM (2)
Labor market (2)
Layoffs (20)
Leadership (1)
Legal (645)
Liver cancer (4)
Lung cancer (15)
Lymphoma (9)
Machine learning (9)
Manufacturing (77)
MASH (4)
Medical device (513)
Medtech (513)
Mergers & acquisitions (1578)
Metabolic disorders (48)
Multiple sclerosis (8)
NASH (2)
Neurodegenerative disease (16)
Neuropsychiatric disorders (8)
Neuroscience (203)
NextGen: Class of 2026 (446)
Non-profit (183)
Now hiring (3)
Obesity (22)
Opinion (31)
Ovarian cancer (7)
Pain (10)
Pancreatic cancer (4)
Parkinson's disease (34)
Partnered (5)
Patents (43)
Patient recruitment (18)
Peanut (1)
People (4363)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase 1 (1288)
Phase 2 (1644)
Phase 3 (1147)
Pipeline (299)
Policy (17)
Postmarket research (122)
Preclinical (812)
Press Release (6)
Prostate cancer (19)
Psychedelics (3)
Radiopharmaceuticals (9)
Rare diseases (47)
Real estate (546)
Recruiting (1)
Regulatory (1458)
Reports (5)
Research institute (237)
Resumes & cover letters (31)
Rett syndrome (7)
RNA editing (1)
RSV (5)
Schizophrenia (27)
Series A (18)
Series B (9)
Sickle cell disease (5)
Spinal muscular atrophy (22)
Sponsored (4)
Startups (331)
Supply chain (9)
Tariffs (5)
Vaccines (43)
Venture capital (5)
Weight loss (13)
Women's health (1)
Worklife (1)
Date
Today (4)
Last 7 days (23)
Last 30 days (95)
Last 365 days (1371)
2026 (137)
2025 (1405)
2024 (2026)
2023 (2472)
2022 (5297)
2021 (4546)
2020 (3248)
2019 (2952)
2018 (2311)
2017 (2454)
2016 (2647)
2015 (3090)
2014 (2434)
2013 (1887)
2012 (2026)
2011 (2306)
2010 (1786)
Location
Africa (90)
Alabama (2)
Arizona (8)
Arkansas (1)
Asia (3323)
Australia (512)
California (629)
Canada (143)
China (63)
Colorado (44)
Connecticut (32)
Delaware (6)
Europe (7570)
Florida (116)
Georgia (3)
Idaho (4)
Illinois (23)
India (2)
Indiana (14)
Iowa (2)
Japan (20)
Kansas (6)
Louisiana (1)
Maine (3)
Maryland (56)
Massachusetts (356)
Michigan (16)
Minnesota (26)
Missouri (3)
Nebraska (1)
Nevada (2)
New Jersey (149)
New Mexico (1)
New York (121)
North Carolina (69)
North Dakota (1)
Northern California (317)
Ohio (16)
Oklahoma (2)
Oregon (3)
Pennsylvania (66)
Puerto Rico (3)
Rhode Island (1)
South America (135)
South Carolina (3)
Southern California (242)
Tennessee (3)
Texas (67)
United States (1913)
Utah (29)
Virginia (10)
Washington D.C. (3)
Washington State (65)
Wisconsin (4)
50,545 Results for "ampac fine chemicals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Olympus Announces U.S. Launch of the SecureFlex™ Single-Use Fine Needle Biopsy Device
January 29, 2026
·
4 min read
AMPAC FINE CHEMICALS ANNOUNCES EXPANSION OF CAPABILITIES IN CALIFORNIA
AMPAC Fine Chemicals, an SK pharmteco company, adds additional pharmaceutical development and engineering capabilities with the opening of a new Complex Molecule Chemistry & Engineering Center
August 24, 2022
·
2 min read
Legal
CytoDyn’s Former CEO Gets Jail Time, $5.3M+ Fine for Securities Fraud
Nader Pourhassan, who led CytoDyn for nearly 10 years, was convicted in December 2024 of misleading investors regarding the biotech’s investigational COVID-19 and HIV drug, which artificially inflated its share price.
January 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Amaran Biotech Signs MOU with Nippon Fine Chemical
March 7, 2025
·
3 min read
Press Releases
1910 Publishes CANDID-CNS™, an AI Model That Unlocks Beyond Rule of 5 Chemical Space and Stereochemistry to Predict Blood–Brain Barrier Penetration
● CANDID-CNS™ is the new state-of-the-art AI model for BBB penetration: it achieves 87% AUPRC on bRo5 small molecules compared to 56% by Pfizer’s CNS MPO. ● CANDID-CNS™ distinguishes CNS penetrant stereoisomers at 68% compared to 50% by Pfizer’s CNS MPO. ● Published in the Journal of Chemical Information and Modeling, CANDID-CNS™ presents a breakthrough in AI Drug Discovery by unlocking the potential of bRo5 and stereochemistry to significantly expand the chemical space of small molecules that can be developed into CNS therapeutics.
December 4, 2025
·
1 min read
Press Releases
Breakthrough T1D Encouraged by Promising Results of FINE-ONE Phase 3 Clinical Trial Evaluating Finerenone for Chronic Kidney Disease Associated with Type 1 Diabetes
November 7, 2025
·
2 min read
Leadership
The Four Employment Agreement Questions Every Pharma Executive Must Ask
Clarity on employment terms is essential to protect careers. In this column, Kaye/Bassman’s Michael Pietrack speaks to employment attorney Howard Matalon, JD, partner at OlenderFeldman, on how to evaluate the fine print of an employment agreement.
December 18, 2025
·
6 min read
·
Michael Pietrack
Business
AMPAC Fine Chemicals Announces Realignment of Their Executive Team
AMPAC Fine Chemicals (AFC) is pleased to announce that effective today Mr. Chris Conley will assume the added responsibilities as Vice President, Human Resources in addition to his position as Vice President, Safety, Health and Environment (SH&E).
March 4, 2019
·
2 min read
Business
AMPAC Fine Chemicals Expands And Focuses Executive Team
AMPAC Fine Chemicals (AFC) is pleased to announce the promotion of Dr. Jeff Butler to the position of Vice President, Project Management and the expansion of Vice President Larry Zeagler’s position as the Head of AFC’s Operations in Petersburg, Virginia
February 14, 2019
·
2 min read
Business
OrphAI Therapeutics Announces Appointment of Jay Fine to Board of Directors
OrphAI Therapeutics Inc. announced the appointment of Jay S. Fine, Ph.D. to its Board of Directors.
January 24, 2024
·
2 min read
1 of 5,055
Next